Omega Fund Management, LLC
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | $1,713,751,848 | Pooled investment vehicles (100%) |
| Apr 2025 to Mar 2026 | $1,799,390,730 | Pooled investment vehicles (100%) |
| Apr 2024 to Mar 2025 | $1,592,308,964 | Pooled investment vehicles (100%) |
| May 2023 to Mar 2024 | $1,394,723,335 | Pooled investment vehicles (100%) |
| Apr 2023 | $1,394,723,335 | Pooled investment vehicles (100%) |
| Apr 2022 to Mar 2023 | $1,911,362,032 | Pooled investment vehicles (100%) |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.8%; sector active share 90.6% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
10 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $185,685,947 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | −570,000 | 1,822,150 | $54,099,633 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ODTX | Odyssey Therapeutics, Inc. | 2,893 | $54,128 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| REPL | Replimune Group, Inc. | 248,672 | $1,902,340 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Reduced | 1,822,150 | $54,099,633 | 29.14% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Held | 8,081,089 | $45,900,585 | 24.72% | |
| KMTS |
Kestra Medical Technologies, Ltd.
Healthcare
|
Held | 1,022,149 | $26,003,470 | 14.00% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Held | 3,289,661 | $25,067,216 | 13.50% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Held | 1,316,183 | $20,624,587 | 11.11% | |
| ALMS |
Alumis Inc.
Healthcare
|
Held | 241,255 | $6,788,915 | 3.66% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
Held | 843,750 | $2,944,687 | 1.59% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Held | 455,361 | $2,686,629 | 1.45% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 876,357 | $1,516,097 | 0.82% | |
| ODTX |
Odyssey Therapeutics, Inc.
Healthcare
|
NEW | 2,893 | $54,128 | 0.03% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.